Inventor · disambiguated record
Doris Riether
Also filed as: RIETHER DORIS · RIETHER DORIS E
49 granted patents·5 pending applications·547 citations·filing 2003–2023
98Inventor score
Files withBOEHRINGER INGELHEIM INT20BARTOLOZZI ALESSANDRA9CENTREXION THERAPEUTICS CORP6BERRY ANGELA5BOEHRINGER INGELHEIM PHARMA4
Top patents by PatentIndex Score
54 records- 0197US7595397B2Compounds which modulate the CB2 receptorBOEHRINGER INGELHEIM INT·Filed 2006·Granted Sep 29, 2009·90 cites·4 claims
- 0296US8173638B2Compounds which modulate the CB2 receptorBERRY ANGELA·Filed 2007·Granted May 8, 2012·25 cites·8 claims
- 0395US8048899B2Compounds which selectively modulate the CB2 receptorBOEHRINGER INGELHEIM INT·Filed 2009·Granted Nov 1, 2011·40 cites·32 claims
- 0493US8999975B2Substituted N- [1-cyano-2- (phenyl) ethyl] -2-azabicyclo [2.2.1] heptane-3-carboxamide inhibitors of cathepsin CGRUNDL MARC·Filed 2012·Granted Apr 7, 2015·27 cites·7 claims
- 0593US7935715B2Compounds which modulate the CB2 receptorBOEHRINGER INGELHEIM INT·Filed 2007·Granted May 3, 2011·34 cites·3 claims
- 0693US7928123B2Compounds which modulate the CB2 receptorBOEHRINGER INGELHEIM INT·Filed 2007·Granted Apr 19, 2011·32 cites·8 claims
- 0792US8362039B2Therapeutic uses of compounds which selectively modulate the CB2 receptorBOEHRINGER INGELHEIM INT·Filed 2011·Granted Jan 29, 2013·17 cites·20 claims
- 0892US6903215B2Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereofBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Jun 7, 2005·51 cites·23 claims
- 0991US11725004B2(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazolesCENTREXION THERAPEUTICS CORP·Filed 2021·Granted Aug 15, 2023·1 cites·16 claims
- 1091US11084810B2(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazolesCENTREXION THERAPEUTICS CORP·Filed 2020·Granted Aug 10, 2021·2 cites·18 claims
- 1191US8349871B2Therapeutic uses of compounds which selectively modulate the CB2 receptorBOEHRINGER INGELHEIM INT·Filed 2011·Granted Jan 8, 2013·15 cites·6 claims
- 1289US10570125B2(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazolesCENTREXION THERAPEUTICS CORP·Filed 2018·Granted Feb 25, 2020·4 cites·20 claims
- 1389US8329735B2Tetrazole compounds which selectively modulate the CB2 receptorERMANN MONIKA·Filed 2011·Granted Dec 11, 2012·26 cites·11 claims
- 1489US8178568B2Sulfone compounds which modulate the CB2 receptorREGAN JOHN·Filed 2009·Granted May 15, 2012·26 cites·19 claims
- 1588US10112934B2(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazolesCENTREXION THERAPEUTICS CORP·Filed 2017·Granted Oct 30, 2018·4 cites·25 claims
- 1688US8629157B2Pyrrolidine compounds which modulate the CB2 receptorBERRY ANGELA·Filed 2009·Granted Jan 14, 2014·14 cites·10 claims
- 1788US8299103B2Compounds which selectively modulate the CB2 receptorBARTOLOZZI ALESSANDRA·Filed 2010·Granted Oct 30, 2012·12 cites·15 claims
- 1888US8299111B2Compounds which modulate the CB2 receptorBERRY ANGELA·Filed 2010·Granted Oct 30, 2012·14 cites·9 claims
- 1987US8546563B2Compounds which modulate the CB2 receptorBERRY ANGELA·Filed 2008·Granted Oct 1, 2013·12 cites·10 claims
- 2086US12344601B2(cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazolesCENTREXION THERAPEUTICS CORP·Filed 2023·Granted Jul 1, 2025·0 cites·20 claims
- 2186US8865744B1(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazolesRIETHER DORIS·Filed 2014·Granted Oct 21, 2014·8 cites·5 claims
- 2286US8372874B2Compounds which selectively modulate the CB2 receptorBOEHRINGER INGELHEIM INT·Filed 2009·Granted Feb 12, 2013·6 cites·12 claims
- 2385US9884854B2N-[(pyrimidinylamino)propanyl]-and N[(pyrazinylamino)proppanyl]arylcarboxamidesBOEHRINGER INGELHEIM INT·Filed 2017·Granted Feb 6, 2018·6 cites·4 claims
- 2485US7553966B2Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereofBOEHRINGER INGELHEIM PHARMA·Filed 2004·Granted Jun 30, 2009·19 cites·8 claims
- 2584US9650370B2(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazolesCENTREXION THERAPEUTICS CORP·Filed 2014·Granted May 16, 2017·5 cites·32 claims
- 2683US9174980B2Heterocyclic compounds as inhibitors of leukotriene productionBARTOLOZZI ALESSANDRA·Filed 2013·Granted Nov 3, 2015·4 cites·9 claims
- 2782US8580829B2Oxadiazole inhibitors of leukotriene productionBARTOLOZZI ALESSANDRA·Filed 2011·Granted Nov 12, 2013·8 cites·18 claims
- 2882US8383615B2Azetidine 2-carboxamide derivatives which modulate the CB2 receptorBOEHRINGER INGELHEIM INT·Filed 2010·Granted Feb 26, 2013·6 cites·17 claims
- 2981US8889670B2Heterocyclic compounds which modulate the CB2 receptorBARTOLOZZI ALESSANDRA·Filed 2010·Granted Nov 18, 2014·6 cites·13 claims
- 3081US8829034B2Compounds which modulate the CB2 receptorBERRY ANGELA·Filed 2011·Granted Sep 9, 2014·6 cites·9 claims
- 3180US8735430B2Compounds which selectively modulate the CB2 receptorBARTOLOZZI ALESSANDRA·Filed 2012·Granted May 27, 2014·6 cites·13 claims
- 3277US8957063B2Amine and ether compounds which modulate the CB2 receptorCIRILLO PIER FRANCESCO·Filed 2009·Granted Feb 17, 2015·6 cites·5 claims
- 3377US8846936B2Sulfonyl compounds which modulate the CB2 receptorHICKEY EUGENE RICHARD·Filed 2011·Granted Sep 30, 2014·6 cites·14 claims
- 3476US7928103B2Compounds which modulate the CB2 receptorBOEHRINGER INGELHEIM INT·Filed 2007·Granted Apr 19, 2011·2 cites·7 claims
- 3574US8658661B2Oxadiazole inhibitors of leukotriene productionBARTOLOZZI ALESSANDRA·Filed 2011·Granted Feb 25, 2014·3 cites·20 claims
- 3666US8575201B2Oxadiazole inhibitors of leukotriene productionBARTOLOZZI ALESSANDRA·Filed 2011·Granted Nov 5, 2013·1 cites·24 claims
- 3763US8741897B2Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereofBEKKALI YOUNES·Filed 2004·Granted Jun 3, 2014·3 cites·3 claims
- 3860US11324724B2N-(2,2-difluoroethyl)-N-[(pyrimidinylamino)propanyl]arylcarboxamidesBOEHRINGER INGELHEIM INT·Filed 2018·Granted May 10, 2022·0 cites·8 claims
- 3956US11236072B2N-[(pyrimidinylamino)propanyl]-,n-[pyridylamino)propanyl]- and n-[(pyrazinylaminol)propanyl]arylcarboxamidesBOEHRINGER INGELHEIM INT·Filed 2018·Granted Feb 1, 2022·0 cites·5 claims
- 4056US10710984B2N-[(Pyrimidinylamino)propanyl]-and N-[(Pyridinylamino)-propanyl]arylcarboxamidesBOEHRINGER INGELHEIM INT·Filed 2017·Granted Jul 14, 2020·0 cites·8 claims
- 4155US10787432B2N-[(pyridyloxy)propanyl]benzamidesBOEHRINGER INGELHEIM INT·Filed 2017·Granted Sep 29, 2020·0 cites·4 claims
- 4255US8212040B2Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereofBEKKALI YOUNES·Filed 2006·Granted Jul 3, 2012·0 cites·11 claims
- 4350US2010261708A1Diazepane Compounds Which Modulate The CB2 ReceptorBOEHRINGER INGELHEIM INT·Filed 2008·Application pending·0 cites
- 4449US10738031B2N-[(heteroaryloxy)propanyl]heteroaryl carboxamides as antagonists of orexin subtype 1 receptor activityBOEHRINGER INGELHEIM INT·Filed 2017·Granted Aug 11, 2020·0 cites·9 claims
- 4549US10604511B2N-[(pyrazinyloxy)propanyl]benzamides as antagonists of orexin subtype 1 receptor activityBOEHRINGER INGELHEIM INT·Filed 2017·Granted Mar 31, 2020·0 cites·8 claims
- 4649US9029360B2Pyrazolopyrimidines as metabotropic glutamate 5 receptor antagonistsGOTTSCHLING DIRK·Filed 2013·Granted May 12, 2015·0 cites·5 claims
- 4747US2009275611A1Compounds Which Modulate The CB2 ReceptorBOEHRINGER INGELHEIM INT·Filed 2007·Application pending·0 cites
- 4846US2012015988A1Sulfone Compounds Which Modulate The CB2 ReceptorHICKEY EUGENE RICHARD·Filed 2009·Application pending·0 cites
- 4944US2006030608A1Anti aromatase compounds pharmaceutical compositions and uses thereofBOEHRINGER INGELHEIM PHARMA·Filed 2005·Application pending·0 cites
- 5041US10392369B2N-[(pyrimidinyloxy)propanyl]benzamidesBOEHRINGER INGELHEIM INT·Filed 2017·Granted Aug 27, 2019·0 cites·11 claims
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Doris Riether files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →